Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Jäntti, Pauliina
DOB:	31-DEC-1988 (Age: 36)
Gender:	female
Address:	Ranna 57 41534 Kohtla-Järve (Estonia)
ID:	8003-808788-0

Report
Date:	25-JUN-2020

Laboratory

Requested by
Poliklinnik Nooruse 3 41536 Jõhvi (Estonia)

Specimen
Collected:	24-JUN-2020

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Hematology

Test	24 Jun 2020	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	6.9	3.5 - 10.5	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	4.6	4.2 - 5.2	10*6/uL
Hemoglobin [Mass/volume] in Blood	13.0	12 - 16	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	36.7 L	37 - 46	%
MCV [Entitic volume] by Automated count	83.3	82 - 98	fL
MCH [Entitic mass] by Automated count	32.1	27 - 34	pg
MCHC [Mass/volume] by Automated count	33.0	31 - 35	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	43.4	36 - 55	fL
Platelets [#/volume] in Blood by Automated count	294.0	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	200.8 H	11.6 - 17.4	fL
Platelet mean volume [Entitic volume] in Blood by Automated count	9.9	9.4 - 12	fL

Chemistry

Test	24 Jun 2020	Reference Range	Unit
Cholesterol [Mass/volume] in Serum or Plasma	267.5 H	130 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	121.4	35 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	193.8 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	49.4	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistently elevated total and LDL cholesterol, indicating increased cardiovascular risk; triglycerides and HDL are within normal limits. Hematology is largely unremarkable except for a slightly low hematocrit and markedly elevated platelet distribution width, which may warrant further evaluation if clinically indicated. Recommend addressing dyslipidemia and monitoring hematological parameters as appropriate.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistently elevated total and LDL cholesterol, indicating increased cardiovascular risk; triglycerides and HDL are within normal limits. Hematology is largely unremarkable except for a slightly low hematocrit and markedly elevated platelet distribution width, which may warrant further evaluation if clinically indicated. Recommend addressing dyslipidemia and monitoring hematological parameters as appropriate.